As COVID-19 Vaccinations Increase Among People in Their 30s... Interest in 'Anaphylaxis Insurance' Also Rises

[Asia Economy Reporter Oh Hyung-gil] As the number of COVID-19 vaccine recipients increases, interest in 'Anaphylaxis Shock Insurance' that guarantees compensation for vaccine side effects is also rising.

On the 10th, LINA Life Insurance announced that the proportion of male subscribers in their 30s for the 'Safe Anaphylaxis Shock Diagnosis Insurance' has recently increased significantly.

According to Naver Data Lab and Kakao Data Trend, the average search volume for 'vaccine insurance' among men in their 30s was only around 5 since the insurance launch on March 25, but after the introduction of the Janssen vaccine on June 1, it has maintained an average of over 50 until the 9th.

LINA Life explained that since the launch of the related insurance, the proportion of subscribers in their 30s surged sharply from the 1st of this month. In particular, the increase in the proportion of men in their 30s was notable as pre-reservations for the Janssen vaccine targeting reservists and civil defense personnel began. The share of subscribers in their 30s who signed up for the Anaphylaxis Shock Diagnosis Insurance this month increased by 159% compared to before. Among men, it surged by 189%, and among women, it rose by 42%.

This product pays up to 2 million KRW once upon the first diagnosis of anaphylaxis shock confirmed due to various causes. The eligible age for subscription is from 20 to 70 years old, and it is a pure protection type with a one-year term.

This content was produced with the assistance of AI translation services.